One DNA Test Now Screens for Genetic Disease Parentage and Coat Traits Simultaneously and That Changes Breed Management

Genetic testing for dogs has historically meant choosing between tests — one for this disease marker, another for coat colour genetics, a separate panel for parentage verification. A study evaluating a targeted next-generation sequencing panel on 95 Doberman Pinscher and Toy Poodle samples has demonstrated that a single cost-effective panel can assess all of these simultaneously — and has confirmed the presence and allele frequencies of significant disease-associated variants in the Doberman population tested. 🐾

Researchers A. Arizmendi, G. Rudd Garces, G. Giovambattista, and their team evaluated a Canine Targeted Genotyping-by-Sequencing custom panel across 76 Doberman Pinschers and 19 Toy Poodles from Argentina. The panel covered 383 targets: 228 parentage SNVs, 137 genetic disorder markers, and 18 trait markers. Three disease markers — for Progressive rod-cone degeneration, von Willebrand disease type 1, and dilated cardiomyopathy — were independently validated by pyrosequencing and Sanger sequencing, showing 94 to 100 percent concordance with the panel results. The methodology’s performance, its limitations, and the specific disease variant prevalence findings in these breed populations are all relevant for owners and breeders working with these dogs.

What the Panel Found in the Doberman Population

Of the 17 polymorphic markers identified across the two breeds — four genetic disorder markers, three hair type markers, and ten coat colour markers — the disease-associated findings in the Doberman population are the most clinically significant. The three validated disease markers covered conditions that Doberman owners and breeders already have reason to monitor closely based on what the breed genetics research covered earlier in this series established.

Progressive rod-cone degeneration is a hereditary eye condition causing progressive photoreceptor degeneration and eventual blindness. von Willebrand disease type 1 is the most common inherited bleeding disorder in dogs, with Dobermans being one of the most frequently affected breeds — the variant responsible produces reduced von Willebrand factor activity that impairs normal clotting and creates surgical and trauma bleeding risk. Dilated cardiomyopathy is the leading cause of death in Dobermans, accounting for 28 percent of breed mortality in the large genomic study covered in this series.

Finding all three of these variants detectable within a single sequencing panel — and confirming allele frequencies in an Argentine Doberman population — provides both a practical screening tool and epidemiological data on how common these variants are in a South American breeding population that is geographically and lineage-distinct from the European and US populations covered in other research.

The Parentage Finding That Breeders Need to Understand ⚠️

The parentage analysis performance revealed an important limitation that has direct implications for breeds with high inbreeding levels. Correct duo parentage assignment — where one parent is compared against offspring — achieved 97.4 percent accuracy with a strong statistical confidence threshold. Trio parentage assignment — where both parents and offspring are compared — achieved 100 percent accuracy. These are strong performance figures for most purposes.

However, in highly inbred populations, the panel proved insufficient for excluding close relatives. Close relatives were wrongly assigned as parents in 12.6 percent of duos and 0.3 percent of trios. This is not a flaw in the sequencing technology — it is a mathematical consequence of the genetic similarity that inbreeding creates. When individuals share the same alleles across the panel not because they are parent and offspring but because they are siblings or half-siblings in a genetically compressed population, the panel cannot reliably distinguish the relationship type.

The Doberman’s 40 percent mean genomic inbreeding — documented in the earlier Wade et al. research in this series — makes this limitation directly relevant for this breed. Parentage verification tools developed for outbred populations may underperform in breeds with the Doberman’s level of genomic compression, and breeders using these panels for parentage confirmation should be aware that close-relative misassignment is a real risk in highly inbred lineages.

What This Technology Means for the Future of Breed Health Management 🐕

The broader significance of cost-effective multi-target sequencing panels for canine genetics is the democratisation of genomic health screening. When a single test can simultaneously assess disease variant status, parentage, and trait markers at accessible cost and with high throughput — the study describes the panel as a cost-effective strategy for large-scale routine genetic evaluation — the barrier to comprehensive genetic health management in breeding programmes drops substantially.

For Doberman breeders specifically, the combination of disease markers covered in this panel addresses the three most practically significant heritable conditions in the breed beyond cardiac disease already covered by existing health programmes. Von Willebrand disease type 1 screening before surgery or in anticipation of trauma risk is already recommended practice in Dobermans — having it integrated into a comprehensive genetic panel alongside cardiomyopathy markers and eye disease screening means fewer separate tests and more complete information from a single sampling event.

For owners, the practical message is straightforward: ask about comprehensive genetic screening when acquiring a Doberman puppy from a breeder. A breeder whose programme includes panel-based genetic evaluation of disease markers in breeding stock is a breeder who is making informed decisions about which variants they are managing across generations — and that information directly shapes the health probability of every puppy produced.

At Zoeta Dogsoul, seeing the whole animal accurately begins before the puppy arrives. NeuroBond is built on genuine understanding of the dog — and for a breed with the Doberman’s known genetic health challenges, that understanding includes knowing which disease variants are present, absent, or carried in the specific animal whose care you are taking on. Genetic knowledge is not a replacement for attentive observation. It is the context that makes observation more precise and more meaningful. 🐾

Source: Arizmendi, A., Rudd Garces, G., et al. (2022). Analysis of Doberman Pinscher and Toy Poodle samples with targeted next-generation sequencing. Gene. Published November 1, 2022.